← Leaderboards
Ye Ding
Georgia State University
$1,949,479
Attributed
$1,949,479
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $390K · FY2021–25$500K$375K$250K$125K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,949,479 · 1
By mechanism
R01$1,949,479 · 1
Top collaborators
No co-investigators on record.
Most similar at Georgia State University
Same institution · by research overlap
- Bingzhong Xue$7,491,301
- Michael Alex Thomas$62,376
Others in their field
Other Emerging Leaders on “Adipocytes”
- Joshua Wiley Knowles · Stanford University$7,127,868
- Paul Cohen · Rockefeller University$6,495,860
- Yajing Wang · Thomas Jefferson University$4,560,590
- Meilian Liu · University Of New Mexico Health Scis Ctr$4,159,426
- Clary B Clish · Broad Institute, Inc.$4,119,923
- Abeer M Mohamed · University Of Illinois At Chicago$3,923,810
Research focus
AdipocytesAngiogenesisAdipose TissueAttenuatedBindingBinding SitesAortaBlood VesselsCancer Cell LineCardiovascular DiseasesCell LineCellsCholesterolComorbidityBlood Glucose RegulationCytoplasmic TailDietDockingDoseEndotheliumEpidemiologic DataEpidermal Growth Factor ReceptorExtracellular DomainFluorescein-5-Isothiocyanate
Grant awards (5)
Elucidating Vascular Neuropilin 1 (NRP1) Functions in Response to Novel Interactions with Insulin Substrates$390,000
R01 · FY2025 · HL · contact PI
Elucidating Vascular Neuropilin 1 (NRP1) Functions in Response to Novel Interactions with Insulin Substrates$390,000
R01 · FY2024 · HL · contact PI
Elucidating Vascular Neuropilin 1 (NRP1) Functions in Response to Novel Interactions with Insulin Substrates$390,000
R01 · FY2023 · HL · contact PI
Elucidating Vascular Neuropilin 1 (NRP1) Functions in Response to Novel Interactions with Insulin Substrates$390,000
R01 · FY2022 · HL · contact PI
Elucidating Vascular Neuropilin 1 (NRP1) Functions in Response to Novel Interactions with Insulin Substrates$389,479
R01 · FY2021 · HL · contact PI